Wednesday, 24 March 2021

AstraZeneca COVID-19 Vaccine 76% Effective In Updated US Trial Results

AstraZeneca said on Thursday its COVID-19 vaccine was 76% effective at preventing symptomatic illness, citing a new analysis of up-to-date results for its major US trial.

from NDTV News - Special https://ift.tt/2PoiJbV
via

No comments:

Post a Comment

Lower Entry Barriers After Record Antitrust Fine: Alibaba As Shares Rally

Alibaba Group CEO Daniel Zhang said on Monday he does not expect any material impact from the change of exclusivity arrangement imposed by C...